Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dog Diseases | 18 | 2015 | 30 | 1.670 |
Why?
|
| Cat Diseases | 4 | 2015 | 7 | 0.960 |
Why?
|
| Horse Diseases | 2 | 2015 | 3 | 0.530 |
Why?
|
| Eye Neoplasms | 1 | 2015 | 8 | 0.480 |
Why?
|
| Melanoma | 1 | 2015 | 153 | 0.420 |
Why?
|
| Dogs | 18 | 2015 | 509 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 3 | 2009 | 523 | 0.400 |
Why?
|
| Eye Infections, Bacterial | 2 | 2004 | 123 | 0.370 |
Why?
|
| Abscess | 2 | 2009 | 24 | 0.360 |
Why?
|
| Bird Diseases | 8 | 2018 | 12 | 0.330 |
Why?
|
| Orbital Diseases | 1 | 2009 | 7 | 0.310 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 42 | 0.310 |
Why?
|
| Bacterial Infections | 1 | 2009 | 56 | 0.300 |
Why?
|
| Animals | 31 | 2018 | 10399 | 0.260 |
Why?
|
| Cats | 5 | 2015 | 51 | 0.260 |
Why?
|
| Orbital Neoplasms | 2 | 2002 | 11 | 0.260 |
Why?
|
| Animals, Wild | 3 | 2002 | 13 | 0.230 |
Why?
|
| Animals, Laboratory | 1 | 2002 | 7 | 0.200 |
Why?
|
| Lizards | 1 | 2002 | 12 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2002 | 52 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 164 | 0.170 |
Why?
|
| Depressive Disorder | 1 | 2021 | 56 | 0.170 |
Why?
|
| Brain Concussion | 1 | 2021 | 48 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 330 | 0.160 |
Why?
|
| Corneal Opacity | 2 | 2018 | 4 | 0.160 |
Why?
|
| Corneal Ulcer | 2 | 2006 | 12 | 0.150 |
Why?
|
| Falconiformes | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cataract Extraction | 3 | 2005 | 29 | 0.140 |
Why?
|
| Horses | 2 | 2015 | 35 | 0.130 |
Why?
|
| Cornea | 4 | 2018 | 68 | 0.130 |
Why?
|
| Platelet-Rich Plasma | 1 | 2015 | 8 | 0.120 |
Why?
|
| Leg Injuries | 1 | 2015 | 10 | 0.120 |
Why?
|
| Male | 17 | 2021 | 13487 | 0.120 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2015 | 5 | 0.120 |
Why?
|
| Female | 19 | 2021 | 15156 | 0.120 |
Why?
|
| Eye Infections, Parasitic | 1 | 2014 | 1 | 0.120 |
Why?
|
| Myiasis | 1 | 2014 | 2 | 0.120 |
Why?
|
| Diptera | 1 | 2014 | 7 | 0.120 |
Why?
|
| Vitreous Body | 2 | 2005 | 22 | 0.110 |
Why?
|
| Conjunctiva | 3 | 1995 | 14 | 0.100 |
Why?
|
| Endophthalmitis | 3 | 2009 | 119 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 633 | 0.090 |
Why?
|
| Horner Syndrome | 1 | 1989 | 1 | 0.080 |
Why?
|
| Brucella canis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Brucellosis | 1 | 2009 | 6 | 0.080 |
Why?
|
| Keratoconjunctivitis | 1 | 1988 | 4 | 0.080 |
Why?
|
| Keratoconjunctivitis Sicca | 1 | 1988 | 4 | 0.080 |
Why?
|
| Uveitis | 2 | 1985 | 23 | 0.070 |
Why?
|
| Facial Nerve Diseases | 1 | 1987 | 1 | 0.070 |
Why?
|
| Administration, Topical | 2 | 2005 | 30 | 0.070 |
Why?
|
| Ophthalmic Solutions | 2 | 2005 | 27 | 0.070 |
Why?
|
| Eyelids | 2 | 1995 | 3 | 0.070 |
Why?
|
| Herpesvirus 1, Canid | 1 | 2006 | 1 | 0.070 |
Why?
|
| Herpesviridae Infections | 1 | 2006 | 17 | 0.060 |
Why?
|
| Vitiligo | 1 | 1985 | 6 | 0.060 |
Why?
|
| Pigmentation Disorders | 1 | 1985 | 8 | 0.060 |
Why?
|
| Retinal Degeneration | 2 | 2004 | 150 | 0.060 |
Why?
|
| Hair Diseases | 1 | 1985 | 6 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2006 | 112 | 0.060 |
Why?
|
| Ofloxacin | 1 | 2005 | 4 | 0.060 |
Why?
|
| Ciprofloxacin | 1 | 2005 | 22 | 0.060 |
Why?
|
| Cataract | 1 | 1984 | 25 | 0.060 |
Why?
|
| Animals, Domestic | 1 | 2004 | 6 | 0.060 |
Why?
|
| Rodent Diseases | 1 | 2004 | 4 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2002 | 372 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 80 | 0.060 |
Why?
|
| Incidence | 2 | 2021 | 562 | 0.050 |
Why?
|
| Veterinary Medicine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Microphthalmos | 2 | 1985 | 5 | 0.050 |
Why?
|
| Cephalosporins | 1 | 2002 | 18 | 0.050 |
Why?
|
| Ceftazidime | 1 | 2002 | 15 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2002 | 25 | 0.050 |
Why?
|
| Blepharitis | 1 | 1981 | 1 | 0.050 |
Why?
|
| Spirurida Infections | 1 | 1981 | 1 | 0.050 |
Why?
|
| Eyelid Diseases | 1 | 1981 | 7 | 0.050 |
Why?
|
| Conjunctivitis | 1 | 1981 | 4 | 0.050 |
Why?
|
| Birds | 7 | 1985 | 25 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2002 | 71 | 0.050 |
Why?
|
| Nevada | 1 | 2021 | 5 | 0.040 |
Why?
|
| Optic Nerve | 1 | 1981 | 28 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 3123 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2557 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2021 | 120 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 886 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 968 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1249 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 94 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 208 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 473 | 0.030 |
Why?
|
| Rupture | 1 | 2015 | 12 | 0.030 |
Why?
|
| Anterior Chamber | 1 | 1995 | 6 | 0.030 |
Why?
|
| Eye | 2 | 2004 | 36 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 28 | 0.030 |
Why?
|
| Eye Injuries | 2 | 1983 | 11 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 2731 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 825 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 976 | 0.020 |
Why?
|
| Wound Healing | 1 | 1990 | 125 | 0.020 |
Why?
|
| Tears | 1 | 1988 | 10 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1988 | 73 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 126 | 0.020 |
Why?
|
| Spasm | 1 | 1987 | 4 | 0.020 |
Why?
|
| Facial Muscles | 1 | 1987 | 8 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 1987 | 12 | 0.020 |
Why?
|
| Otitis Media | 1 | 1987 | 35 | 0.020 |
Why?
|
| Umbilicus | 1 | 1967 | 3 | 0.020 |
Why?
|
| Fistula | 1 | 1967 | 17 | 0.020 |
Why?
|
| Humans | 2 | 2021 | 28121 | 0.020 |
Why?
|
| Retina | 3 | 1985 | 433 | 0.020 |
Why?
|
| Idoxuridine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Trifluridine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Corneal Diseases | 1 | 1985 | 21 | 0.020 |
Why?
|
| Mydriatics | 1 | 1985 | 6 | 0.020 |
Why?
|
| Retinal Detachment | 1 | 1985 | 11 | 0.020 |
Why?
|
| Syndrome | 1 | 1985 | 78 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 1985 | 11 | 0.020 |
Why?
|
| Orbit | 1 | 1985 | 8 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1985 | 75 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 2005 | 33 | 0.010 |
Why?
|
| Ultrasonic Therapy | 1 | 1984 | 4 | 0.010 |
Why?
|
| Oculomotor Muscles | 1 | 1984 | 17 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2005 | 148 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 62 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2005 | 105 | 0.010 |
Why?
|
| Skin | 1 | 1985 | 148 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 1 | 0.010 |
Why?
|
| Ophthalmoscopy | 1 | 2004 | 6 | 0.010 |
Why?
|
| Animal Population Groups | 1 | 1983 | 1 | 0.010 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 1983 | 23 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 191 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1982 | 31 | 0.010 |
Why?
|
| Urticaria Pigmentosa | 1 | 1981 | 1 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1981 | 27 | 0.010 |
Why?
|
| Vitamin E Deficiency | 1 | 1981 | 1 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1982 | 265 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2005 | 613 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1981 | 47 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 2380 | 0.010 |
Why?
|
| United States | 1 | 2004 | 2149 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 4645 | 0.010 |
Why?
|
| Bacteria | 1 | 1995 | 281 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1985 | 18 | 0.000 |
Why?
|
| Lens, Crystalline | 1 | 1985 | 6 | 0.000 |
Why?
|
| Silicone Elastomers | 1 | 1983 | 4 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1983 | 28 | 0.000 |
Why?
|
| New York | 1 | 1982 | 17 | 0.000 |
Why?
|
| Retinal Vessels | 1 | 1982 | 72 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1981 | 20 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1981 | 94 | 0.000 |
Why?
|